Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tarkan Jäger, Matthias Ocker, Tobias Kiesslich, Elen Neureiter & Daniel Neureiter. (2017) Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer. Expert Opinion on Investigational Drugs 26:2, pages 133-136.
Read now
Read now
Articles from other publishers (19)
Huaqing Jing, Yingzi Ren, Yue Zhou, Min Xu, Sona Krizkova, Zbynek Heger, Qiang Lu, Siyu Wang, Xiaoyang Liang, Vojtech Adam & Nan Li. (2023) Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity. Acta Pharmaceutica Sinica B 13:12, pages 5030-5047.
Crossref
Crossref
Daniel L. Pouliquen, Alice Boissard, Cécile Henry, Olivier Coqueret & Catherine Guette. (2022) Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. Frontiers in Pharmacology 13.
Crossref
Crossref
Pengju Liu, Jianfeng Zeng & Gaohua Yang. (2022) Expression of yes‑associated protein, β‑catenin and smoothened, and their clinical significance in invasive breast cancer. Experimental and Therapeutic Medicine 23:6.
Crossref
Crossref
Wei-Wei Chen, Kai-Kai Gong, Li-Juan Yang, Juan-Juan Dai, Qian Zhang, Feng Wang, Xue-Lin Li, Si-Chuan Xi & Jing Du. (2021) Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop. Journal of Ethnopharmacology 265, pages 113295.
Crossref
Crossref
Ruowen Zhang, Jinlu Ma, Justin T. Avery, Vijaya Sambandam, Theresa H. Nguyen, Bo Xu, Mark J. Suto & Rebecca J. Boohaker. (2020) GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer. Frontiers in Oncology 10.
Crossref
Crossref
Mariana Verdelho Machado & Anna Mae Diehl. 2020. The Liver. The Liver
539
549
.
Wenjun Chen, Jing Song, Hongjun Bian, Xia Yang, Xiaoyu Xie, Qiang Zhu, Chengyong Qin & Jianni Qi. (2020) The functions and targets of miR‐212 as a potential biomarker of cancer diagnosis and therapy. Journal of Cellular and Molecular Medicine 24:4, pages 2392-2401.
Crossref
Crossref
Ana Bela Sarmento-Ribeiro, Andreas Scorilas, Ana Cristina Gonçalves, Thomas Efferth & Ioannis P. Trougakos. (2019) The emergence of drug resistance to targeted cancer therapies: Clinical evidence. Drug Resistance Updates 47, pages 100646.
Crossref
Crossref
Balaram S. Takale, Ruchita R. Thakore, Fan Yi Kong & Bruce H. Lipshutz. (2019) An environmentally responsible 3-pot, 5-step synthesis of the antitumor agent sonidegib using ppm levels of Pd catalysis in water. Green Chemistry 21:23, pages 6258-6262.
Crossref
Crossref
Farshad N. Chowdhury, Julie Reisinger, Karina E. Gomez, Tugs-Saikhan Chimed, Carissa M. Thomas, Phuong N. Le, Bettina Miller, John J. Morton, Cera M. Nieto, Hilary L. Somerset, Xiao-Jing Wang, Stephen B. Keysar & Antonio Jimeno. (2019) Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function. Oral Oncology 98, pages 118-124.
Crossref
Crossref
Priyanka Bhateja, Mathew Cherian, Sarmila Majumder & Bhuvaneswari Ramaswamy. (2019) The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?. Cancers 11:8, pages 1126.
Crossref
Crossref
Georg Richtig, Alena M Aigelsreiter, Martin Asslaber, Thomas Weiland, Martin Pichler, Katharina Eberhard, Stephan Sygulla, Silvia Schauer, Gerald Hoefler & Ariane Aigelsreiter. (2019) Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma. Histopathology 75:1, pages 118-127.
Crossref
Crossref
Daniel Girardi, Adriana Barrichello, Gustavo Fernandes & Allan Pereira. (2019) Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives. Cells 8:2, pages 153.
Crossref
Crossref
Francesca Ghirga, Mattia Mori & Paola Infante. (2018) Current trends in Hedgehog signaling pathway inhibition by small molecules. Bioorganic & Medicinal Chemistry Letters 28:19, pages 3131-3140.
Crossref
Crossref
Chenglin Wang, Mingfei Zhu, Xiuhong Lu, Hong Wang, Weili Zhao, Xiongwen Zhang & Xiaochun Dong. (2018) Synthesis and evaluation of novel dimethylpyridazine derivatives as hedgehog signaling pathway inhibitors. Bioorganic & Medicinal Chemistry 26:12, pages 3308-3320.
Crossref
Crossref
Michaël H. Meel, Sophie A. Schaper, Gertjan J. L. Kaspers & Esther Hulleman. (2017) Signaling pathways and mesenchymal transition in pediatric high-grade glioma. Cellular and Molecular Life Sciences 75:5, pages 871-887.
Crossref
Crossref
Xiuhong Lu, Yuanqiu Peng, Chenglin Wang, Jun Yang, Xiaolong Bao, Qian Dong, Weili Zhao, Wenfu Tan & Xiaochun Dong. (2017) Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors. European Journal of Medicinal Chemistry 138, pages 384-395.
Crossref
Crossref
Andrew C. Flick, Hong X. Ding, Carolyn A. Leverett, Robert E. KyneJr.Jr., Kevin K. -C. Liu, Sarah J. Fink & Christopher J. O’Donnell. (2017) Synthetic Approaches to the New Drugs Approved During 2015. Journal of Medicinal Chemistry 60:15, pages 6480-6515.
Crossref
Crossref
Jing Du, Weiwei Chen, Lijuan Yang, Juanjuan Dai, Jiwei Guo, Yan Wu, Kaikai Gong, Jian Zhang, Ning Yu, Zhen Xie & Sichuan Xi. (2017) Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment. Scientific Reports 7:1.
Crossref
Crossref